Filippo Pederzoli

About Filippo Pederzoli

Filippo Pederzoli, With an exceptional h-index of 26 and a recent h-index of 25 (since 2020), a distinguished researcher at Università Vita-Salute San Raffaele,

His recent articles reflect a diverse array of research interests and contributions to the field:

Lipidomic profiling as a biomarker for prostate cancer diagnosis and response to enzalutamide (Enza).

Distinct mesenchymal cell states mediate prostate cancer progression

Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer

Progressive alteration of murine bladder elasticity in actinic cystitis detected by Brillouin microscopy

Early diagnosis of bladder cancer by tumor-targeted gold nanorods

Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should We Revisit the Goals of Care?

Whole exome data prioritization unveils the hidden weight of Mendelian causes of male infertility. A report from the first Italian cohort

Stromal cells in prostate cancer pathobiology: friends or foes?

Filippo Pederzoli Information

University

Position

___

Citations(all)

2123

Citations(since 2020)

2064

Cited By

644

hIndex(all)

26

hIndex(since 2020)

25

i10Index(all)

54

i10Index(since 2020)

54

Email

University Profile Page

Google Scholar

Top articles of Filippo Pederzoli

Lipidomic profiling as a biomarker for prostate cancer diagnosis and response to enzalutamide (Enza).

2024/2/1

Distinct mesenchymal cell states mediate prostate cancer progression

Nature Communications

2024/1/8

Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer

European Urology

2024/1/5

Progressive alteration of murine bladder elasticity in actinic cystitis detected by Brillouin microscopy

Scientific Reports

2024/1/4

Filippo Pederzoli
Filippo Pederzoli

H-Index: 14

Early diagnosis of bladder cancer by tumor-targeted gold nanorods

European Urology Open Science

2023/10/1

Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should We Revisit the Goals of Care?

Urology

2023/10/1

Whole exome data prioritization unveils the hidden weight of Mendelian causes of male infertility. A report from the first Italian cohort

Plos one

2023/8/4

Stromal cells in prostate cancer pathobiology: friends or foes?

2023/4/6

Mesenchymal cell populations associated with different stages of prostate cancer progression in mice and human

Cancer Research

2023/4/4

Concomitant vs Staged Therapeutic Inguinal Lymphadenectomy in Clinically Node Positive Penile Squamous Cell Carcinoma: Does It Make a Difference?

The Journal of Urology

2023/3

Micro-mechanical fingerprints of the rat bladder change in actinic cystitis and tumor presence

Communications Biology

2023/2/24

Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy …

Journal of Translational Medicine

2023/2/3

A global approach to improving penile cancer care

2022/4

The Relationship of Circumcision With Clinical Tumor Staging of Penile Cancer

Société Internationale d'Urologie Journal

2022/3/4

Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints

2022/2/1

Filippo Pederzoli
Filippo Pederzoli

H-Index: 14

Francesco Montorsi
Francesco Montorsi

H-Index: 6

Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature

2022/2

Filippo Pederzoli
Filippo Pederzoli

H-Index: 14

Francesco Montorsi
Francesco Montorsi

H-Index: 6

Re: MultiparametricMagnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer: Preliminary Findings …

THE JOURNAL OF UROLOGY

2022

Author Correction: A global approach to improving penile cancer care

2022

Pathologic Features of Response to Neoadjuvant Therapies in Muscle-Invasive Bladder Cancer: More than Meets the Eye

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers: Multidisciplinary Management

2022

Filippo Pederzoli
Filippo Pederzoli

H-Index: 14

The Gut and Urinary Microbiota: A Rising Biomarker in Genitourinary Malignancies

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers: Multidisciplinary Management

2022

Filippo Pederzoli
Filippo Pederzoli

H-Index: 14

See List of Professors in Filippo Pederzoli University(Università Vita-Salute San Raffaele)